Acute Liver Failure

Download as ppt, pdf, or txt
Download as ppt, pdf, or txt
You are on page 1of 39

Acute Liver

Failure
MUTUA W. MUTHEU
Topics

 Definitions of failure and classification


 Aetiology- Acute versus acute on chronic
 Basic diagnostic workup
 Treatment of complication
 Hepatic encephalopathy
 Coagulopathy
 Specialist centre referral
 Organ support
The mortality rate for acute liver failure ranges between 56% and 80%
 UK incidence of cirrhosis 17 per 100,000
 Prevalence of cirrhosis is 76 per 100,000
 ALF incidence is 1-6 per million per year
Formal diagnosis of acute liver failure

 An increase in PT by 4-6 seconds (INR>1.5)

 And the development of hepatic encephalopathy (HE).

 In a patient without pre-existing cirrhosis and with an illness of less than


six months duration.
Definition; Jaundice to HE

 Hyperacute- <7days

 Acute - >7days <21days

 Subacute- >21days <6months

 FHF- not used


Stages of Hepatic Encephalopathy:

Stage 0. Lack of detectable changes in personality or


behaviour. Asterixis absent.

Stage 1. Trivial lack of awareness. Shortened attention


span. Impaired addition or subtraction. Hypersomnia,
insomnia, or inversion of sleep pattern. Euphoria or
depression. Asterixis can be detected.

Stage 2. Lethargy or apathy. Disorientation.


Inappropriate behaviour. Slurred speech. Obvious
asterixis.

Stage 3. Gross disorientation. Bizarre behaviour.


Semistupor to stupor. Asterixis generally absent.

Stage 4. Coma.
Worldwide cause varies
Diagnostics:

 Good history-
difficult if HE
Diagnosis and Initial
Evaluation ALF
 HISTORY:
 Family members with liver disease?
 Recent cold sores
 Onset of jaundice
 Work environment- toxic agents
 Hobbies/travel
 Herbal products/dietary supplements
Initial Laboratory Analysis

 Prothrombin time/INR
 Chemistries
 Liver enzymes
 Arterial blood gas
 Paracetamol level, Toxicology screen
 Viral hepatitis serologies (anti-HAV IgM,
HBsAg, anti-HBc IgM, anti-HEV, anti-HCV, HCV
RNA , HSV1 IgM, VZ/HS, EB, CMV)
Initial Laboratory Analysis

 Ceruloplasmin level
 Pregnancy test (females)
 Ammonia (arterial if possible)
 Autoimmune Markers (ANA, ASMA, Immunoglobulin
levels )
Liver biopsy for diagnostic dilemma

 Importance of early biopsy- severity and aetiology


 Particularly useful in Hep B, Autoimmune, Alcoholic hepatitis,
differentiate between ALF and ACLF

 Transjugular route
What are the potential
outcomes?
 Recovery because of a successful
intervention
 NAC for paracetamol toxicity
 Antivirals for acute hepatitis B

 Spontaneous recovery with


supportive care
 Death

 Rescue by liver transplant (OLT)


Aetiology outcome for ALF

Transplant free survival >50%


Hepatitis A, FLDP, paracetamol

Transplant free survival <25%


Autoimmune, HEB, Wilsons, mushroom, idiosyncratic drug
All Liver transplants

 CLD – 60%
 Malignancy- 10%
 ALF- 10% ( Paracetamol)
 Cholestasis - 10-20%
King’s College Criteria LT

 Acetaminophen-Induced
ALF:
 Strongly consider OLT listing if:
 arterial lactate >3.5 mmol/L after early fluid resuscitation
 List for OLT if: pH<7.3 Or
 arterial lactate >3.0 mmol/L after adequate fluid
resuscitation
 List for OLT if all 3 occur within a 24-hour period:
 1- presence of grade 3 or 4 hepatic encephalopathy
 2- INR >6.5
 3- Creatinine >3.4 mg/dL
King’s College Criteria LT

Non-acetaminophen:
 INR > 6.5 OR
 Any 3 of the following 5:
 Age < 10 or > 40
 Serum bilirubin > 300
 Jaundice to encephalopathy interval > 7 days
 INR > 3.5
 Unfavorable Etiology
 Non-A, non-B hepatitis, halothane, idiosyncratic drug
reaction, Wilson’s
 Stage I – 0-24h
 Asymptomatic
 GI upset
 LFT derangement at 12h
 Stage 2 – 24-48h
 RUQ pain, tenderness
 LFT derrangment, bilirubin, PT
 Stage 3 – 48-96h
 Centrilobar necrosis
 Liver failure
 Stage 4
 Recovery, transplant or death
 No chronic state
Encephalopathy
HE- Four compatible theories

 Cerebral vasomotor dysfunction


 Oedema secondary to ammonia toxicity
 Inflammation due to SIRS
 putative benzodiazepine-like molecules
The pathophysiology of HE

 Ammonia as a key factor in the


pathogenesis of HE.
 Portal ammonia is derived from both the
 urease activity of colonic bacteria and the
 de-amidation of glutamine in the small bowel.
 The intact liver clears almost all of the
portal vein ammonia, converting it into
glutamine and preventing entry into the
systemic circulation.
 Ammonia- astrocyte swelling in brain
Cerebral Edema

 Degree of encephalopathy correlates w/ cerebral


edema
 Grade I-II: rare
 Grade III: 25-35% risk risk
 Grade IV: 65-75% risk
 Uncal herniation
 Compromises cerebral blood flow  hypoxic brain
injury
Grade III/IV Encephalopathy

 Intubate trachea + ventilate


 Elevate head of bed
 Consider placement of ICP monitoring device
 Immediate treatment of seizures required; prophylaxis
of unclear value
 Mannitol: use for severe elevation of ICP or first clinical
signs of herniation
 Hypertonic saline to raise serum sodium to 145-155
mmol/L
 Hyperventilation: effects short-lived; may use for
impending herniation
GCS –HE correlation

 Grade1- GCS 14-15


 Grade2- GCS 11-13- HDU

 Grade3- GCS 8-11 (Stupor or precoma)


 Grade4- GCS<8 (Coma)
Lactulose is a first-line
pharmacological treatment of
HE.
 Lactulose – reaches colon, where
bacteria will metabolize the lactulose
to acetic acid and lactic acid.
 This lowers the colonic pH
 formation of the non-absorbable NH4+
from NH3,
 Other effects like catharsis also
contribute to the clinical effectiveness
of lactulose.
Lactulose

 For acute encephalopathy, lactulose (ingested


or via nasogastric tube), 45 ml p.o.,

 Is followed by dosing every hour until


evacuation occurs.
 Target -three soft bowel movements per day

 If response to disachharide is poor- add


antibiotic (metronidazole or rifaximine after
48Hrs) to reduce enteric bacterial mass.
The coagulopathy of liver
disease
 Failure to produce clotting factors II, V, VII and IX
 The degree of coagulopathy is a measure of severity of liver
disease and of patient prognosis.
 Routine correction of coaguloapthy is therefore NOT
indicated unless active bleeding or planned
interventions require it
 Vitamin K: give at least one dose
 FFP: give only for invasive procedures or active bleeding
 Platelets: give only for invasive procedures or active bleeding
 Recombinant activated factor VII: possibly effective for invasive
procedures
Role of prophylactic
antibiotic
 Only patients who have an episode of gastrointestinal
bleeding
 or an episode of spontaneous bacterial peritonitis (SBP)
have been shown to have a significant outcome benefit
from prophylactic antibiotics.
Role of NAC

 Efficacy of NAC is well established in


paracetamol induced ALF
 Non PCM ALF – role of NAC is controversial
 However most recent studies has improved
outcome
 175 patients of non PCM ALF received NAC
 Transplant free survival at 3 weeks was 52% in
NAC group compared to 30% in placebo arm
( only with coma grade of 1-2)
 United States ALF study group- overall was 70%
vs 66%
Artificial liver??
Extracorporeal Liver Assist
Device (ELAD)
 Hepatocyte bioreactor- hepatoma cells cultivated on
the exterior surface of semipermeable hollow fibres

 MARS (molecular adsorbent recirculating system)


ELAD

 Both reduce the level of bilirubin, bile salt ammonia etc


 However no of patients dying or requiring liver
transplant did not improve

Devices remain experimental and large-


scale phase two and three trials are
awaited
Case 2

 55yo Male, builder bricklayer


 PMH
 Alcohol abuse (abstinent)
 Recurrent ascites
 Oesophageal varices
 Meds
 Thiamine, vit B12, furosemide/amiloride, lactulose,
propranolol
Case 2

 PC
 Tired, fatigued, reversal of sleep wake pattern,
generalized slowness,
 Exam
 Spider naevi, no asterixis, splenomegally, mild shifting
dullness, INR 1.3, plt 115, Hb 14.5, MCV 101, alb 48, ALP
110, ALT 32
 What next ?...
Stages of Hepatic Encephalopathy:

Stage 0. Lack of detectable changes in personality or


behaviour. Asterixis absent.

Stage 1. Trivial lack of awareness. Shortened attention


span. Impaired addition or subtraction. Hypersomnia,
insomnia, or inversion of sleep pattern. Euphoria or
depression. Asterixis can be detected.

Stage 2. Lethargy or apathy. Disorientation.


Inappropriate behaviour. Slurred speech. Obvious
asterixis.

Stage 3. Gross disorientation. Bizarre behaviour.


Semistupor to stupor. Asterixis generally absent.

Stage 4. Coma.
Acute on Chronic Liver Failure
ACLF

 This entity is quite common- background of cirrhosis.


Innocent precipitating event culminates in Massive
Organ Failure (OF)
 Events
 Toxins (alcohol!)
 Vascular (hypotension- GI bleed, dehydration, Portal vein
thrombosis)
 Infection (SBP)
Summary
• The mortality rate for acute liver failure ranges between 56% and 80%

• Careful history taking and examination of lab results help identify


patients

• The commonest cause of acute liver failure in the western world is


paracetamol toxicity

 Some causes have low survival without OLT, prompt referral…

• Hepatic encephalopathy is no longer the main cause of death but it’s


detection and management requires sophisticated cardiovascular and
cerebral monitoring

• Acute on Chronic Liver Failure

You might also like